Search results
Author(s):
Xianxian Jiang
Added:
3 years ago
Author(s):
Kenichiro Yamagata
,
Bashar Aldhoon
,
Josef Kautzner
Added:
3 years ago
The number of catheter ablations for atrial fibrillation (AF) treatment has gradually increased over the last 15 years since the first report on the importance of pulmonary vein (PV) foci for triggering AF.1 Catheter ablation for AF is a complex procedure with multiple steps, such as transseptal puncture, mapping of the left atrium and PVs and extensive linear ablation around PV ostia. Not…
View more
Zero X-ray Ablation
Author(s):
Giuseppe Mascia
,
Marzia Giaccardi
Added:
3 years ago
Article
Author(s):
Rohil Bedi
,
Ali Ahmad
,
Piotr Horbal
,
et al
Added:
7 months ago
Author(s):
Eun-Jeong Kim
,
Giovanni Davogustto
,
William G Stevenson
,
et al
Added:
3 years ago
Myocardial scars from infarction or replacement fibrosis in non-ischaemic cardiomyopathies are the common substrate for sustained monomorphic ventricular tachycardia (VT).1,2 In selected patients at high risk of ventricular arrhythmias, placement of an implantable cardioverter-defibrillator (ICD) is effective for prevention of sudden cardiac death.2 Although ICDs are effective in terminating VT…
View more
Author(s):
Chen Wei
,
Pierre Qian
,
Usha B Tedrow
,
et al
Added:
3 years ago
Ventricular tachycardia (VT) is a life-threatening sequela found in patients with cardiomyopathy. ICDs can terminate ventricular arrhythmias, but recurrent device shocks lead to reduced quality of life and are associated with higher mortality.1–5 Radiofrequency catheter ablation has emerged as an effective treatment for VT refractory to anti-arrhythmic therapy and has also been shown to reduce…
View more
Added:
3 years ago
Dr Phillip S Cuculich (Washington University, St. Louis, MO, US) shares the longer term results from a Phase I/II Study Of EP-guided Noninvasive Cardiac Radioablation for Treatment of Ventricular Tachycardia.
HRS 2020:Recorded remotely from Washington.
Interviewer: Mirjam Boros
Recording editor: Natascha Wienand
Transcript Below:
My name is Phillip Cuculich, and on behalf of my colleagues…
View more
Author(s):
Tom JR De Potter
,
Gazmend Bardhaj
,
Aniello Viggiano
,
et al
Added:
3 years ago
Percutaneous catheter treatment for atrial fibrillation (AF) has seen an exponential uptake since the first cases were published exactly two decades ago.1 Evolving over different approaches and treatment strategies, current standard of care consists of pulmonary vein isolation (PVI) through radiofrequency (RF) or other energy sources. While this treatment has been shown to be superior to…
View more
Author(s):
Venkatesh Ravi
,
Jeffrey Winterfield
,
Jackson J Liang
,
et al
Added:
1 year ago
Author(s):
Katrina Mountfort
Added:
3 years ago
New oral anticoagulants (NOACs), including dabigatran1 (a direct thrombin inhibitor), apixaban,2 rivaroxaban3 and edoxaban4 (activated factor Xa inhibitors, not yet approved) have become alternatives to vitamin K antagonists (VKAs) for thromboembolic prevention in patients with non-valvular atrial fibrillation (AF), as a result of their numerous clinical advantages. However, there is a need for a…
View more